recombinant human il 17a Search Results


recombinant human il  (R&D Systems)
92
R&D Systems recombinant human il
Recombinant Human Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17%2FIL-17A+Protein/pm19543237-184-0-6
Average 92 stars, based on 1 article reviews
recombinant human il - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
human il 17a  (R&D Systems)
95
R&D Systems human il 17a
Human Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A+(Human+Cell-expressed)+Protein/pmc03571997-218-6-18
Average 95 stars, based on 1 article reviews
human il 17a - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
murine il 17a  (R&D Systems)
95
R&D Systems murine il 17a
Murine Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A+Protein%2C+CF/pm20231694-82-6-16
Average 95 stars, based on 1 article reviews
murine il 17a - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
recombinant human interleukin 17a il 17a  (R&D Systems)
95
R&D Systems recombinant human interleukin 17a il 17a
Recombinant Human Interleukin 17a Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A+Protein%2C+CF/pmc05698596-173-0-4
Average 95 stars, based on 1 article reviews
recombinant human interleukin 17a il 17a - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
il 17 group  (Proteintech)
93
Proteintech il 17 group
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
Il 17 Group, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Animal-free+Recombinant+Human+IL-17/pmc12951635-54-1-9
Average 93 stars, based on 1 article reviews
il 17 group - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
µmol l recombinant human il 17a  (R&D Systems)
93
R&D Systems µmol l recombinant human il 17a
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
µmol L Recombinant Human Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A+(Human+Cell-expressed)+Protein/ppr0779881-44-23-27
Average 93 stars, based on 1 article reviews
µmol l recombinant human il 17a - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
recombinant il 17  (Novus Biologicals)
91
Novus Biologicals recombinant il 17
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
Recombinant Il 17, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17%2FIL-17A+Protein/pm36977695-244-24-27
Average 91 stars, based on 1 article reviews
recombinant il 17 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
il 17af  (R&D Systems)
94
R&D Systems il 17af
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
Il 17af, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A%2FF+Heterodimer+Protein/pmc10146571-40-9-10
Average 94 stars, based on 1 article reviews
il 17af - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
recombinant human il 17a  (R&D Systems)
94
R&D Systems recombinant human il 17a
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
Recombinant Human Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A+Biotinylated+Protein%2C+CF/pmc03142078-39-55-58
Average 94 stars, based on 1 article reviews
recombinant human il 17a - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
human il 17a f heterodimer  (R&D Systems)
94
R&D Systems human il 17a f heterodimer
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
Human Il 17a F Heterodimer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A%2FF+Heterodimer+Protein/pm27594509-38-9-34
Average 94 stars, based on 1 article reviews
human il 17a f heterodimer - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
recombinant il 17a f  (R&D Systems)
94
R&D Systems recombinant il 17a f
Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
Recombinant Il 17a F, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+il+17a/Recombinant+Human+IL-17A%2FF+Heterodimer+(CHO-expressed)%2C+CF/pmc05064647-90-9-12
Average 94 stars, based on 1 article reviews
recombinant il 17a f - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in IL-17–stimulated keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.

Journal: Frontiers in Pharmacology

Article Title: Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17–mediated inflammation

doi: 10.3389/fphar.2026.1754729

Figure Lengend Snippet: Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in IL-17–stimulated keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.

Article Snippet: The IL-17 group was treated with 100 ng/mL IL-17 (Proteintech; HZ-1113); the Lico B group received 9 μM Lico B (MCE; HY-N3388); the IL-17 + Lico B group was co-treated with IL-17 and Lico B; and the control group was treated with PBS.

Techniques: Biomarker Discovery, In Vitro, In Vivo, Western Blot, Immunofluorescence, Staining, Flow Cytometry

Schematic illustration of lico B treatment in psoriasis. Lico B modulates lipid metabolic pathways by suppressing SCD1-dependent metabolic reprogramming and reducing lipid droplet accumulation in keratinocyte, while simultaneously attenuating the TH17/IL-17 axis. Through concurrent regulation of keratinocyte metabolism and inflammatory cytokine production, Lico B ameliorate psoriatic skin pathology.

Journal: Frontiers in Pharmacology

Article Title: Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17–mediated inflammation

doi: 10.3389/fphar.2026.1754729

Figure Lengend Snippet: Schematic illustration of lico B treatment in psoriasis. Lico B modulates lipid metabolic pathways by suppressing SCD1-dependent metabolic reprogramming and reducing lipid droplet accumulation in keratinocyte, while simultaneously attenuating the TH17/IL-17 axis. Through concurrent regulation of keratinocyte metabolism and inflammatory cytokine production, Lico B ameliorate psoriatic skin pathology.

Article Snippet: The IL-17 group was treated with 100 ng/mL IL-17 (Proteintech; HZ-1113); the Lico B group received 9 μM Lico B (MCE; HY-N3388); the IL-17 + Lico B group was co-treated with IL-17 and Lico B; and the control group was treated with PBS.

Techniques: